Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,437 | 84 | 99.8% |
| Education | $2.69 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $462.23 | 36 | $0 (2024) |
| GlaxoSmithKline, LLC. | $202.46 | 13 | $0 (2024) |
| PROCEPT BioRobotics Corporation | $119.04 | 1 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $115.72 | 6 | $0 (2019) |
| Medtronic, Inc. | $100.00 | 1 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $80.81 | 6 | $0 (2019) |
| Novo Nordisk Inc | $58.81 | 4 | $0 (2024) |
| Stryker Corporation | $52.03 | 2 | $0 (2024) |
| Allergan Inc. | $47.63 | 3 | $0 (2018) |
| Daiichi Sankyo Inc. | $44.90 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $210.15 | 10 | Stryker Corporation ($52.03) |
| 2023 | $119.04 | 1 | PROCEPT BioRobotics Corporation ($119.04) |
| 2022 | $114.47 | 2 | Medtronic, Inc. ($100.00) |
| 2020 | $73.29 | 5 | GlaxoSmithKline, LLC. ($62.13) |
| 2019 | $276.40 | 21 | PFIZER INC. ($148.17) |
| 2018 | $356.02 | 25 | PFIZER INC. ($173.72) |
| 2017 | $290.14 | 21 | PFIZER INC. ($126.10) |
All Payment Transactions
85 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/23/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: Endocrinology | ||||||
| 09/10/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: Iron Deficiency Anemia | ||||||
| 07/02/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/12/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $24.60 | General |
| Category: Iron Deficiency Anemia | ||||||
| 06/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: Diabetes | ||||||
| 05/23/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: RESPIRATORY | ||||||
| 05/22/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $26.22 | General |
| Category: UROLOGY | ||||||
| 05/03/2024 | Stryker Corporation | T2 (Device), PRO, VARIAX | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: TRAUMA & EXTREMETIES | ||||||
| 03/11/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: RESPIRATORY | ||||||
| 02/01/2024 | Stryker Corporation | T2 ALPHA (Device) | Food and Beverage | In-kind items and services | $36.56 | General |
| Category: TRAUMA & EXTREMITIES | ||||||
| 03/23/2023 | PROCEPT BioRobotics Corporation | AQUABEAM ROBOTIC SYSTEM (Device) | Food and Beverage | In-kind items and services | $119.04 | General |
| Category: Urology | ||||||
| 09/14/2022 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 07/27/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: RESPIRATORY | ||||||
| 12/22/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: RESPIRATORY | ||||||
| 06/08/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: RESPIRATORY | ||||||
| 02/12/2020 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), BOOSTRIX, ENGERIX-B | Food and Beverage | In-kind items and services | $12.95 | General |
| Category: VACCINES | ||||||
| 01/16/2020 | GlaxoSmithKline, LLC. | ANORO ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.51 | General |
| Category: RESPIRATORY | ||||||
| 01/08/2020 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $11.16 | General |
| Category: Diabetes | ||||||
| 12/19/2019 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: RESPIRATORY | ||||||
| 12/17/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $8.74 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 12/03/2019 | PFIZER INC. | PREVNAR - 13 (Biological), TRUMENBA | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: VACCINES | ||||||
| 09/19/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.07 | General |
| Category: RESPIRATORY | ||||||
| 08/13/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $8.84 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/13/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $3.86 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/25/2019 | PFIZER INC. | PREVNAR - 13 (Biological), TRUMENBA | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: VACCINES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 96 | 106 | $12,522 | $4,058 |
| 2022 | 5 | 321 | 569 | $91,449 | $33,955 |
| 2021 | 5 | 276 | 467 | $70,951 | $27,900 |
| 2020 | 6 | 315 | 468 | $62,569 | $23,709 |
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 45 | 52 | $8,904 | $3,036 | 34.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 25 | 27 | $3,240 | $882.22 | 27.2% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 26 | 27 | $378.00 | $140.36 | 37.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 192 | 410 | $72,753 | $26,303 | 36.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 82 | 110 | $13,759 | $5,186 | 37.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 11 | 11 | $2,379 | $1,413 | 59.4% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 18 | 18 | $2,278 | $941.51 | 41.3% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2022 | 18 | 20 | $280.00 | $109.88 | 39.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 167 | 343 | $57,768 | $23,492 | 40.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 56 | 68 | $8,056 | $3,287 | 40.8% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 12 | 12 | $2,016 | $561.50 | 27.9% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 23 | 24 | $2,852 | $466.86 | 16.4% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Office | 2021 | 18 | 20 | $260.00 | $91.70 | 35.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 147 | 281 | $42,408 | $14,952 | 35.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 32 | 32 | $6,368 | $3,631 | 57.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 56 | 67 | $7,142 | $2,278 | 31.9% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 47 | 54 | $4,472 | $1,815 | 40.6% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 16 | 16 | $1,909 | $923.28 | 48.4% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Office | 2020 | 17 | 18 | $270.00 | $109.16 | 40.4% |
About Dr. William Ryan, MD
Dr. William Ryan, MD is a Family Medicine healthcare provider based in Whitesboro, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1104924570.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Ryan, MD has received a total of $1,440 in payments from pharmaceutical and medical device companies, with $210.15 received in 2024. These payments were reported across 85 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($1,437).
As a Medicare-enrolled provider, Ryan has provided services to 1,008 Medicare beneficiaries, totaling 1,610 services with total Medicare billing of $89,621. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Whitesboro, NY
- Active Since 09/20/2006
- Last Updated 11/10/2016
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1104924570
Products in Payments
- ELIQUIS (Drug) $324.18
- AQUABEAM ROBOTIC SYSTEM (Device) $119.04
- TRELEGY ELLIPTA (Drug) $118.53
- XARELTO (Drug) $104.60
- INTELLIS ADAPTIVESTIM (Device) $100.00
- CHANTIX (Drug) $84.22
- JANUVIA (Drug) $54.64
- ANORO (Drug) $45.94
- INJECTAFER (Drug) $44.90
- PREVNAR - 13 (Biological) $40.06
- T2 ALPHA (Device) $36.56
- Victoza (Drug) $29.62
- Ozempic (Drug) $29.19
- GEMTESA (Drug) $26.22
- SHINGRIX (Biological) $24.48
- MYRBETRIQ (Drug) $19.61
- BYSTOLIC (Drug) $18.96
- NAMZARIC (Drug) $17.04
- Edwards SAPIEN 3 Transcatheter Heart Valve (Device) $15.72
- T2 (Device) $15.47
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.